Navigation Links
PrimeraDx Featured in the Goldman Sachs Healthcare Research Team's GS Emerging Healthcare Series
Date:5/9/2013

MANSFIELD, Mass., May 9, 2013 /PRNewswire/ -- PrimeraDx, Inc., a molecular diagnostics company, will be highlighted in a conference call with the Goldman Sachs Healthcare Research Team as part of the GS Emerging Healthcare Series on May 13, 2013 at 11 am.  Matthew McManus , MD, Ph.D., President and CEO of PrimeraDx will provide an overview of the Company's innovative technology and its two-pronged approach to the market: offering an "open platform" system to reference labs, academic medical centers and large hospital systems and also partnering with pharmaceutical companies to develop cutting-edge companion diagnostic products.  Isaac Ro , Goldman Sachs Life Science Tools & Diagnostics Analyst will host the call. 

Dial in information: 877-208-2954 or 973-528-0056
Conference Entry Code: 938134
Webcast: http://www.visualwebcaster.com/event.asp?id=94044

Replay information
Access #: 800.332.6854 OR 973.528.0005
Conference Entry Code: 938134
Dates: 5/13 – 5/27 (2 weeks)

About PrimeraDx
PrimeraDx is a molecular diagnostics company marketing an innovative clinical platform which combines PCR with capillary electrophoresis for multiplexed, information-rich molecular diagnostics used in Oncology, Infectious Disease, and Genetic Testing. The result of combining these two well-known technologies into a bench-top instrument is the ability to deliver highly multiplexed, multi-modal, and quantitative answers to the clinic.  Users can easily design very complex assays that simultaneously test for disparate target types, like SNPs, expression biomarkers, microRNAs and fusion genes. PrimeraDx's technology represents the next generation of quantitative, multiplex PCR. The Company is backed by a strong group of experienced venture-capital investors, including Abingworth, InterWest Partners, CHL Medical Partners, and Malaysian Technology Development Corporation. The Company's website is: www.primeradx.com

CONTACT:  Ted Myles, CFO, (508) 618-2300


'/>"/>
SOURCE PrimeraDx, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. PrimeraDx to Co-Develop Companion Diagnostics with Quest Diagnostics
2. Green Dot’s Terratek Bioplastics to be Featured by Material ConneXion at Luxe Pack and the International Contemporary Furniture Fair
3. Three Dispensing Modes Featured in the New Masterflex I/P Digital Brushless Process Drives from Cole-Parmer
4. Mammotome to Be Featured in Upcoming Episode of Health Heroes
5. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
6. DMG is Proud to Announce that CD Diagnostics will be Featured in an Upcoming Episode of Health Heroes
7. Hud-Son Forest Equipment to be Featured in Upcoming Episode of American Farmer on RFD-TV
8. Nerium Featured in the Newest Issue of Success from Home
9. Emily's Entourage Featured by Rush Order Tees in "One Drop, Many Ripples" Initiative
10. Latest Environmental Research Featured at ScienceAlerts.com
11. VIASPACE Chairman and CEO Attend EUEC 2013, Giant King Grass Prominently Featured in Convention Exhibit Hall
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... Ginkgo Bioworks , a leading organism design company ... as one of the World Economic Forum,s Technology ... companies. Ginkgo Bioworks is engineering biology to manufacture ... the nutrition, health and consumer goods sectors. The ... Fortune 500 companies to design microbes for their ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle ... people with peritoneal or pleural mesothelioma. Their findings are the subject of a new ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology:
(Date:4/28/2016)... and BANGALORE, India , April 28, 2016 ... a product subsidiary of Infosys (NYSE: INFY ), ... a global partnership that will provide end customers ... mobile banking and payment services.      (Logo: ... innovation area for financial services, but it also plays a ...
(Date:4/26/2016)... , April 27, 2016 ... the  "Global Multi-modal Biometrics Market 2016-2020"  report to ... ) , The analysts forecast the ... CAGR of 15.49% during the period 2016-2020.  ... number of sectors such as the healthcare, BFSI, ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
Breaking Biology News(10 mins):